- ►annals.org [PDF] R Tung, S Kaul, GA Diamond, PK Shah - Annals of internal medicine, 2006 - Am Coll Physicians Interventional cardiologists have quickly replaced bare metal stents with
intravascular drug-eluting stents for treating and preventing restenosis,
largely on the basis of empirical evidence that shows profound reduction in ... Cited by 81 - Related articles - BL Direct - All 6 versions
A POCOVÍMTSAC - SciELO Argentina Los stents liberadores de fármacos antiproliferativos (SLF) marcan el último
hito en la evolución del trata- miento endovascular de la enfermedad coronaria.
A los stents convencionales (STC) se los revistió con un polímero y una ... Related articles - View as HTML - All 5 versions
A Pocoví - Revista Argentina de Cardiología, 2006 - SciELO Argentina Los stents liberadores de fármacos antiproliferativos (SLF) marcan el último
hito en la evolución del tratamiento endovascular de la enfermedad coronaria. A
los stents convencionales (STC) se los revistió con un polímero y una ... Related articles - Cached - All 5 versions
DE Kandzari, MT Roe, EM Ohman, S Milford- … - The American journal of cardiology, 2005 - Elsevier Despite the established benefit of drug-eluting stents (DESs) in improving
clinical and angiographic outcomes in pivotal, randomized trials, relatively
little is known regarding the frequency and patterns of DES use in clinical ... Cited by 54 - Related articles - All 13 versions
JA Boechat, J Andréa, L Cortes, F Goldberg, L … - Rev Bras Cardiol Invas, 2005 - rbci.org.br 1 Serviço de Hemodinâmica e Cardiologia Intervencionista. Clínica São
Vicente da Gávea. Rio de Janeiro, RJ. 2 Serviço de Hemodinâmica e Cardiologia
Intervencionista. Hospital CardioTrauma Ipanema. Rio de Janeiro, RJ. ... Related articles - View as HTML - All 2 versions
HK Win, AE Caldera, K Maresh, J Lopez, CS … - Jama, 2007 - Am Med Assoc Context Clinical trials that have excluded patients at high risk for cardiac
events have led to commercial labeling approval of drug-eluting stents;
nevertheless, such high-risk patients commonly undergo stent placement in ... Cited by 152 - Related articles - BL Direct - All 4 versions
- ►ispm-unibasel.ch [PDF] C Kaiser, HP Brunner-La Rocca, PT Buser, PO … - The Lancet, 2005 - Elsevier Cardiac death, myocardial infarction, or target vessel revascularisation
occurred in 39 of 544 (7·2%) patients with DES and 34 of 280 (12·1%) with BMS
(odds ratio 0·56, 95% CI 0·35–0·91; p=0·02), without significant ... Cited by 195 - Related articles - All 16 versions
G Acharya, K Park - Advanced drug delivery reviews, 2006 - Elsevier The clinical importance of drug-eluting stents (DESs) has been demonstrated by
their unparalleled success in preventing restenosis after stenting procedures.
The magnitude of success is historic despite their short history. The ... Cited by 48 - Related articles - All 5 versions
- ►onlinejacc.org S Kaul, PK Shah, GA Diamond - Journal of the American College of Cardiology, 2007 - Elsevier Drug-eluting stents (DES) have dramatically transformed the landscape of
interventional cardiology largely on the basis of empirical evidence showing
profound reduction in angiographic and clinical restenosis without any ... Cited by 31 - Related articles - BL Direct - All 17 versions
